Testing effectiveness (Phase 2)UnknownNCT03612232What this trial is testingCabozantinib in Advanced Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Wuerzburg University Hospital 37
Early research (Phase 1)Not Yet RecruitingNCT07715903What this trial is testingHepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump TherapyWho this might be right forColorectal NeoplasmsNeoplasmsIntrahepatic Cholangiocarcinoma+2 more National Cancer Institute (NCI) 20
Early research (Phase 1)Active Not RecruitingNCT04459273What this trial is testingProspective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various CancersWho this might be right forBladder CarcinomaCervical CarcinomaCholangiocarcinoma+13 more Jonsson Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Not applicableLooking for participantsNCT07027254What this trial is testingPETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary AldosteronismWho this might be right forPrimary AldosteronismSecondary HypertensionAldosterone-Producing Adenoma+2 more Seoul National University Hospital 90
Large-scale testing (Phase 3)Study completedNCT00094497What this trial is testingTrial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)Who this might be right forCarcinoma, Adrenal Cortical Collaborative Group for Adrenocortical Carcinoma Treatment 304
Testing effectiveness (Phase 2)UnknownNCT05885399What this trial is testingThe Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic TreatmentWho this might be right forPheochromocytoma, MetastaticPheochromocytoma MalignantParaganglioma, Malignant Peking Union Medical College Hospital 5
Testing effectiveness (Phase 2)Looking for participantsNCT06066333What this trial is testingStudy of Radiotherapy and Pembrolizumab in People With Adrenocortical CarcinomaWho this might be right forAdrenocortical CarcinomaACCMetastatic Adrenocortical Carcinoma Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04394858What this trial is testingTesting the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine CancerWho this might be right forAdvanced Adrenal Gland PheochromocytomaAdvanced ParagangliomaMetastatic Adrenal Gland Pheochromocytoma+5 more National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT00848016What this trial is testingGossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By SurgeryWho this might be right forRecurrent Adrenocortical CarcinomaStage III Adrenocortical CarcinomaStage IV Adrenocortical Carcinoma National Cancer Institute (NCI) 29
Early research (Phase 1)Ended earlyNCT03746431What this trial is testing[225Ac]-FPI-1434 InjectionWho this might be right forAdvanced Solid TumoursEndometrial CancerCervical Cancer+7 more Fusion Pharmaceuticals Inc. 78
Testing effectiveness (Phase 2)Study completedNCT03370718What this trial is testingCabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical CarcinomaWho this might be right forMetastatic Carcinoma in the Adrenal CortexStage III Adrenal Cortex Carcinoma AJCC v8Stage IV Adrenal Cortex Carcinoma AJCC v8+1 more M.D. Anderson Cancer Center 18
Not applicableActive Not RecruitingNCT05925569What this trial is testingElectronic Alert to Improve Testing For Primary Aldosteronism in Patients With HypertensionWho this might be right forPrimary AldosteronismResistant HypertensionSecondary Hypertension+3 more Brigham and Women's Hospital 12,501
Not applicableUnknownNCT02848196What this trial is testingAn Image-guided SBRT for Adrenal Gland Metastasis in Oligometastatic PatientsWho this might be right forAdrenal Gland Metastases Istituto Clinico Humanitas 40
Not applicableStudy completedNCT02592356What this trial is testingEffect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine CancerWho this might be right forDifferentiated Thyroid Gland CarcinomaMalignant Adrenal Gland PheochromocytomaMalignant Paraganglioma+1 more M.D. Anderson Cancer Center 23
Not applicableLooking for participantsNCT04115254What this trial is testingStereotactic Magnetic Resonance Guided Radiation TherapyWho this might be right forPancreas CancerLung CancerRenal Cancer+10 more Dana-Farber Cancer Institute 397
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743138What this trial is testingSTOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)Who this might be right forAdrenocortical CarcinomaPheochromocytomaParaganglioma M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06333314What this trial is testingDostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIWho this might be right forPancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more UNICANCER 120
Not applicableLooking for participantsNCT06228677What this trial is testingComparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery EmbolizationWho this might be right forResistant HypertensionSecondary HypertensionSecondary Hypertension to Endocrine Disorders+1 more First Affiliated Hospital of Chengdu Medical College 196
Testing effectiveness (Phase 2)Ended earlyNCT05012397What this trial is testingMilademetan in Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorsHead and Neck CarcinomaCholangiocarcinoma+15 more Rain Oncology Inc 40